JP Morgan Chase’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$172M Buy
291,621
+29,406
+11% +$14.6M 0.01% 759
2025
Q4
$128M Buy
262,215
+14,278
+6% +$6.65M 0.01% 839
2025
Q3
$104M Buy
247,937
+5,347
+2% +$1.8M 0.01% 972
2025
Q2
$69.7M Buy
242,590
+41,904
+21% +$12.5M ﹤0.01% 1136
2025
Q1
$61.9M Buy
200,686
+8,430
+4% +$2.89M ﹤0.01% 1195
2024
Q4
$67.8M Sell
192,256
-290
-0.2% -$107K 0.01% 1137
2024
Q3
$69M Buy
192,546
+50,291
+35% +$17M 0.01% 1143
2024
Q2
$45.3M Sell
142,255
-14,734
-9% -$3.9M ﹤0.01% 1302
2024
Q1
$36.1M Sell
156,989
-20,711
-12% -$4.67M ﹤0.01% 1477
2023
Q4
$39.1M Sell
177,700
-8,614
-5% -$1.99M ﹤0.01% 1365
2023
Q3
$42.1M Sell
186,314
-15,839
-8% -$3.65M ﹤0.01% 1197
2023
Q2
$44.6M Sell
202,153
-14,944
-7% -$3.31M 0.01% 1169
2023
Q1
$48.6M Buy
217,097
+34,880
+19% +$8.6M 0.01% 1119
2022
Q4
$50.7M Buy
182,217
+2,279
+1% +$575K 0.01% 1109
2022
Q3
$37.7M Sell
179,938
-3,984
-2% -$891K 0.01% 1185
2022
Q2
$43.3M Sell
183,922
-11,585
-6% -$2.36M 0.01% 1129
2022
Q1
$35.1M Sell
195,507
-1,735
-0.9% -$331K ﹤0.01% 1369
2021
Q4
$42.6M Buy
197,242
+22,287
+13% +$4.38M 0.01% 1293
2021
Q3
$32.3M Sell
174,955
-3,834
-2% -$755K ﹤0.01% 1424
2021
Q2
$32.1M Buy
178,789
+8,386
+5% +$1.6M ﹤0.01% 1466
2021
Q1
$28.5M Buy
170,403
+39,985
+31% +$6.67M ﹤0.01% 1468
2020
Q4
$19.8M Sell
130,418
-39,395
-23% -$5.17M ﹤0.01% 1619
2020
Q3
$17.2M Buy
169,813
+32,747
+24% +$3.59M ﹤0.01% 1602
2020
Q2
$16.6M Buy
137,066
+36,105
+36% +$4.06M ﹤0.01% 1506
2020
Q1
$9.57M Sell
100,961
-495
-0.5% -$47K ﹤0.01% 1782
2019
Q4
$8.94M Buy
101,456
+16,966
+20% +$1.49M ﹤0.01% 2204
2019
Q3
$6.74M Sell
84,490
-5,646
-6% -$455K ﹤0.01% 2440
2019
Q2
$6.94M Sell
90,136
-128,805
-59% -$12M ﹤0.01% 2384
2019
Q1
$25.7M Sell
218,941
-114,875
-34% -$13.4M 0.01% 1372
2018
Q4
$36.4M Sell
333,816
-14,429
-4% -$1.67M 0.01% 1065
2018
Q3
$44.5M Sell
348,245
-243,768
-41% -$30.2M 0.01% 1080
2018
Q2
$67M Sell
592,013
-261,797
-31% -$28.8M 0.01% 831
2018
Q1
$95.9M Buy
853,810
+228,105
+36% +$29M 0.02% 650
2017
Q4
$92.6M Sell
625,705
-14,770
-2% -$1.88M 0.02% 692
2017
Q3
$76.1M Buy
640,475
+139,976
+28% +$17.9M 0.02% 738
2017
Q2
$64.9M Buy
500,499
+378,002
+309% +$47.2M 0.02% 791
2017
Q1
$16.6M Buy
122,497
+2,223
+2% +$337K ﹤0.01% 1583
2016
Q4
$17.3M Buy
120,274
+44,090
+58% +$5.63M ﹤0.01% 1553
2016
Q3
$9M Sell
76,184
-75,197
-50% -$9.04M ﹤0.01% 1861
2016
Q2
$16M Sell
151,381
-108,947
-42% -$12.2M ﹤0.01% 1538
2016
Q1
$29M Buy
260,328
+81,110
+45% +$10.3M 0.01% 1096
2015
Q4
$28.1M Sell
179,218
-5,048
-3% -$735K 0.01% 1113
2015
Q3
$24.2M Sell
184,266
-669
-0.4% -$107K 0.01% 1147
2015
Q2
$32.2M Sell
184,935
-21,675
-10% -$3.9M 0.01% 1120
2015
Q1
$35.6M Sell
206,610
-800
-0.4% -$122K 0.01% 1066
2014
Q4
$26.9M Sell
207,410
-125,114
-38% -$16.1M 0.01% 1287
2014
Q3
$42.8M Sell
332,524
-485,469
-59% -$50M 0.01% 977
2014
Q2
$72.4M Buy
817,993
+303,524
+59% +$29.2M 0.02% 680
2014
Q1
$48.4M Buy
514,469
+283,217
+122% +$29M 0.01% 829
2013
Q4
$26.2M Sell
231,252
-139,541
-38% -$12.6M 0.01% 1173
2013
Q3
$29.2M Buy
370,793
+292,044
+371% +$21.3M 0.01% 1092
2013
Q2
$5.18M Buy
+78,749
New +$5.07M ﹤0.01% 2117

Other funds holding UTHR